1 Min Read
Jan 9 (Reuters) - Immunomedics Inc
* Immunomedics announces reconstituted board of directors and leadership succession plan
* Immunomedics Inc - Announces chairman and CEO succession plans
* Immunomedics Inc - Effective June 30, 2017, Jason Aryeh will assume role of chairman of Immunomedics board.
* Immunomedics Inc - David M. Goldenberg, current chairman, will transition his role, effective June 30, 2017
* Immunomedics Inc - Board will immediately initiate a search for a new CEO Source text for Eikon: Further company coverage: